Concepedia
Statistics
Publications
7
Citations
577
H-Index
Active since
2017
Affiliations
State Key Laboratory of Natural Medicine(Current)
China Pharmaceutical University
Nanjing University of Chinese Medicine
Jingyue Yao is an author at State Key Laboratory of Natural Medicine specializing in molecular oncology, oncology, and life sciences.
Publications per year
2017–2025
CDK9 inhibition blocks the initiation of PINK1-PRKN-mediated mitophagy by regulating the SIRT1-FOXO3-BNIP3 axis and enhances the therapeutic effects involving mitochondrial dysfunction in hepatocellular carcinoma
Jingyue Yao, Jubo Wang, Ye Xu et al. · Autophagy · 2021 · 258 citations · Full text
Life Sciences, Cancer Biology, Cell Biology +14
Oroxylin A suppresses the development and growth of colorectal cancer through reprogram of HIF1α-modulated fatty acid metabolism
Ting Ni, Zihao He, Yuanyuan Dai et al. · Cell Death and Disease · 2017 · 87 citations · Full text
Life Sciences, Biochemistry, Oncology +17
Regulation of AMPK-related glycolipid metabolism imbalances redox homeostasis and inhibits anchorage independent growth in human breast cancer cells
Lin Yang, Zihao He, Jingyue Yao et al. · Redox Biology · 2018 · 80 citations · Full text
RETRACTED ARTICLE: Oroxylin A activates PKM1/HNF4 alpha to induce hepatoma differentiation and block cancer progression
Libin Wei, Yuanyuan Dai, Yuxin Zhou et al. · Cell Death and Disease · 2017 · 70 citations · Full text
Medicine, Oncology, Pharmacology +13
Novel CDK9 inhibitor oroxylin A promotes wild-type P53 stability and prevents hepatocellular carcinoma progression by disrupting both MDM2 and SIRT1 signaling
Jingyue Yao, Shu Xu, Yuening Sun et al. · Acta Pharmacologica Sinica · 2021 · 52 citations · Full text
Medicine, Cancer Biology, Oncology +15
1–5 of 7